No abstract available
MeSH terms
-
2019-nCoV Vaccine mRNA-1273
-
Amino Alcohols / adverse effects
-
Amino Alcohols / chemistry
-
Anaphylaxis / chemically induced*
-
Anaphylaxis / diagnosis
-
Anaphylaxis / pathology
-
BNT162 Vaccine
-
COVID-19 / immunology
-
COVID-19 / pathology
-
COVID-19 / prevention & control*
-
COVID-19 / virology
-
COVID-19 Vaccines / administration & dosage
-
COVID-19 Vaccines / adverse effects*
-
COVID-19 Vaccines / chemistry
-
Decanoates / adverse effects
-
Decanoates / chemistry
-
Excipients / adverse effects
-
Excipients / chemistry
-
Humans
-
Liposomes / administration & dosage
-
Liposomes / adverse effects*
-
Liposomes / immunology
-
Mass Vaccination / statistics & numerical data
-
Nanoparticles / administration & dosage
-
Nanoparticles / adverse effects*
-
Polyethylene Glycols / adverse effects
-
Polyethylene Glycols / chemistry
-
SARS-CoV-2 / pathogenicity
-
Vaccines, Synthetic / administration & dosage
-
Vaccines, Synthetic / adverse effects*
-
Vaccines, Synthetic / chemistry
-
mRNA Vaccines
Substances
-
Amino Alcohols
-
COVID-19 Vaccines
-
Decanoates
-
Excipients
-
Lipid Nanoparticles
-
Liposomes
-
Vaccines, Synthetic
-
Polyethylene Glycols
-
DMG-PEG 2000
-
(4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate)
-
2019-nCoV Vaccine mRNA-1273
-
BNT162 Vaccine